TY - JOUR AU - Oken, M. M. AU - Creech, R. H. AU - Tormey, D. C. AU - Horton, J. AU - Davis, T. E. AU - McFadden, E. T. PY - 1982 DA - 1982// TI - Toxicity and response criteria of the eastern cooperative oncology group JO - Am J Clin Oncol VL - 5 UR - https://doi.org/10.1097/00000421-198212000-00014 DO - 10.1097/00000421-198212000-00014 ID - Oken1982 ER - TY - JOUR AU - DeVita, V. T. AU - Chu, E. PY - 2008 DA - 2008// TI - A history of Cancer chemotherapy JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-6611 DO - 10.1158/0008-5472.CAN-07-6611 ID - DeVita2008 ER - TY - JOUR AU - Chan, W. L. AU - Lam, K. O. AU - Siu, W. K. AU - Yuen, K. K. PY - 2016 DA - 2016// TI - Chemotherapy at end-of-life: an integration of oncology and palliative team JO - Support Care Cancer VL - 24 UR - https://doi.org/10.1007/s00520-015-3031-z DO - 10.1007/s00520-015-3031-z ID - Chan2016 ER - TY - JOUR AU - Roeland, E. J. AU - LeBlanc, T. W. PY - 2016 DA - 2016// TI - Palliative chemotherapy: oxymoron or misunderstanding? JO - BMC Palliat Care VL - 15 UR - https://doi.org/10.1186/s12904-016-0109-4 DO - 10.1186/s12904-016-0109-4 ID - Roeland2016 ER - TY - JOUR AU - Reljic, T. PY - 2017 DA - 2017// TI - Treatment targeted at underying disease versus palliative care in terminally ill patients: a systematic review JO - BMJ Open VL - 7 UR - https://doi.org/10.1136/bmjopen-2016-014661 DO - 10.1136/bmjopen-2016-014661 ID - Reljic2017 ER - TY - JOUR AU - Schnipper, L. E. AU - Smith, T. J. AU - Raghavan, D. AU - Blayney, D. W. AU - Ganz, P. A. AU - Mulvey, T. M. AU - Wollins, D. S. PY - 2012 DA - 2012// TI - American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2012.42.8375 DO - 10.1200/JCO.2012.42.8375 ID - Schnipper2012 ER - TY - JOUR AU - Prigerson, H. G. AU - Bao, Y. AU - Shah, M. A. AU - Paulk, M. E. AU - LeBlanc, T. W. AU - Schneider, B. J. AU - Garrido, M. M. AU - Reid, M. C. AU - Berlin, D. A. AU - Adelson, K. B. PY - 2015 DA - 2015// TI - Chemotherapy Use, Performance Status, and Quality of Life at the End of Life JO - JAMA Oncol VL - 1 UR - https://doi.org/10.1001/jamaoncol.2015.2378 DO - 10.1001/jamaoncol.2015.2378 ID - Prigerson2015 ER - TY - JOUR AU - Crosara Teixeira, M. AU - Marques, D. F. AU - Ferrari, A. C. AU - Alves, M. F. AU - Alex, A. K. AU - Sabbaga, J. AU - Hoff, P. M. AU - Riechelmann, R. P. PY - 2015 DA - 2015// TI - The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4 JO - Clin Colorectal Cancer VL - 14 UR - https://doi.org/10.1016/j.clcc.2014.09.010 DO - 10.1016/j.clcc.2014.09.010 ID - Crosara Teixeira2015 ER - TY - JOUR AU - Ali, M. AU - Cripps, M. C. AU - Balchin, K. AU - Spencer, J. AU - Wheatley-Price, P. PY - 2012 DA - 2012// TI - Palliative inpatient chemotherapy: clinical benefit or harm? JO - J Clin Oncol VL - 30 ID - Ali2012 ER - TY - JOUR AU - Rocque, G. B. AU - Barnett, A. E. AU - Illig, L. C. AU - Eickhoff, J. C. AU - Bailey, H. H. AU - Campbell, T. C. AU - Stewart, J. A. AU - Cleary, J. F. PY - 2013 DA - 2013// TI - Inpatient hospitalization of oncology patients: are we missing an opportunity for end-of-life care? JO - J Oncol Pract VL - 9 UR - https://doi.org/10.1200/JOP.2012.000698 DO - 10.1200/JOP.2012.000698 ID - Rocque2013 ER - TY - STD TI - Rocha LS, Riechelmann RP. Treatment of patients with metastatic colorectal cancer and poor performance status: current evidence and challenges. Clinics. 2018;73(suppl 1):e542s. ID - ref11 ER - TY - JOUR AU - Lee, H. S. AU - Chun, K. H. AU - Moon, D. AU - Lee, S. AU - Lee, S. PY - 2015 DA - 2015// TI - Trends in receiving chemotherapy for advanced cancer patients at the end of life JO - BMC Palliat Care VL - 14 UR - https://doi.org/10.1186/s12904-015-0001-7 DO - 10.1186/s12904-015-0001-7 ID - Lee2015 ER - TY - JOUR AU - Soto-Perez-de-Celis, E. AU - Chavarri-Guerra, Y. AU - Pastrana, T. AU - Ruiz-Mendoza, R. AU - Bukowski, A. AU - Goss, P. E. PY - 2017 DA - 2017// TI - End-of-life Care in Latin America JO - J Glob Oncol VL - 3 UR - https://doi.org/10.1200/JGO.2016.005579 DO - 10.1200/JGO.2016.005579 ID - Soto-Perez-de-Celis2017 ER - TY - JOUR AU - Charlson, M. E. AU - Pompei, P. AU - Ales, K. L. AU - MacKenzie, C. R. PY - 1987 DA - 1987// TI - A new method of classifying prognostic comorbidity in longitudinal studies: development and validation JO - J Chronic Dis VL - 40 UR - https://doi.org/10.1016/0021-9681(87)90171-8 DO - 10.1016/0021-9681(87)90171-8 ID - Charlson1987 ER - TY - JOUR AU - Schouwenburg, M. G. AU - Jochems, A. AU - Leeneman, B. AU - Franken, M. G. AU - Eertwegh, A. J. AU - Haanen, J. B. AU - Zeijl, M. C. AU - Aarts, M. J. AU - Akkooi, A. C. AU - Berkmortel, F. W. AU - Blokx, W. A. PY - 2018 DA - 2018// TI - Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes JO - Melanoma Res VL - 28 ID - Schouwenburg2018 ER - TY - JOUR AU - Harano, K. AU - Lei, X. AU - Gonzalez-Angulo, A. M. AU - Murthy, R. K. AU - Valero, V. AU - Mittendorf, E. A. AU - Ueno, N. T. AU - Hortobagyi, G. N. AU - Chavez-MacGregor, M. PY - 2016 DA - 2016// TI - Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer JO - Breast Cancer Res Treat VL - 59 UR - https://doi.org/10.1007/s10549-016-3933-6 DO - 10.1007/s10549-016-3933-6 ID - Harano2016 ER - TY - JOUR AU - Murad, A. M. AU - Santiago, F. F. AU - Petroianu, A. AU - Rocha, P. R. AU - Rodrigues, M. A. AU - Rausch, M. PY - 1993 DA - 1993// TI - Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer JO - Cancer VL - 72 UR - https://doi.org/3.0.CO;2-P DO - 3.0.CO;2-P ID - Murad1993 ER - TY - JOUR AU - Cunningham, D. AU - Glimelius, B. PY - 1999 DA - 1999// TI - A phase III study of irinotecan (CPT-11) versus best supportive care in patients with metastatic colorectal cancer who have failed 5-fluorouracil therapy. V301 study group JO - Semin Oncol VL - 26 ID - Cunningham1999 ER - TY - JOUR AU - Shepherd, F. A. AU - Dancey, J. AU - Ramlau, R. AU - Mattson, K. AU - Gralla, R. AU - O'Rourke, M. AU - Levitan, N. AU - Gressot, L. AU - Vincent, M. AU - Burkes, R. PY - 2000 DA - 2000// TI - Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy JO - J Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.10.2095 DO - 10.1200/JCO.2000.18.10.2095 ID - Shepherd2000 ER - TY - JOUR AU - Kawaguchi, T. AU - Takada, M. AU - Kubo, A. AU - Matsumura, A. AU - Fukai, S. AU - Tamura, A. AU - Saito, R. AU - Maruyama, Y. AU - Kawahara, M. AU - Ignatius Ou, S. H. PY - 2010 DA - 2010// TI - Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC JO - J Thorac Oncol VL - 5 UR - https://doi.org/10.1097/JTO.0b013e3181d2dcd9 DO - 10.1097/JTO.0b013e3181d2dcd9 ID - Kawaguchi2010 ER - TY - JOUR AU - Sánchez-Muñoz, A. AU - Pérez-Ruiz, E. AU - Sáez, M. I. AU - Trigo, J. M. AU - Galindo, M. M. AU - Manzaneque, L. AU - Jiménez, B. AU - Muros, B. AU - Alba, E. PY - 2011 DA - 2011// TI - Limited impact of palliative chemotherapy on survival in advanced solid tumours in patients with poor performance status JO - Clin Transl Oncol VL - 13 UR - https://doi.org/10.1007/s12094-011-0677-y DO - 10.1007/s12094-011-0677-y ID - Sánchez-Muñoz2011 ER - TY - JOUR AU - Wheatley-Price, P. AU - Ali, M. AU - Balchin, K. AU - Spencer, J. AU - Fitzgibbon, E. AU - Cripps, C. PY - 2014 DA - 2014// TI - The role of palliative chemotherapy in hospitalized patients JO - Curr Oncol VL - 21 UR - https://doi.org/10.3747/co.21.1989 DO - 10.3747/co.21.1989 ID - Wheatley-Price2014 ER - TY - JOUR AU - Matsuyama, R. AU - Reddy, S. AU - Smith, T. J. PY - 2006 DA - 2006// TI - Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.03.6236 DO - 10.1200/JCO.2005.03.6236 ID - Matsuyama2006 ER - TY - JOUR AU - Earle, C. C. AU - Neville, B. A. AU - Landrum, M. B. AU - Ayanian, J. Z. AU - Block, S. D. AU - Weeks, J. C. PY - 2004 DA - 2004// TI - Trends in the aggressiveness of Cancer care near the end of life JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.08.136 DO - 10.1200/JCO.2004.08.136 ID - Earle2004 ER - TY - JOUR AU - Wright, A. A. AU - Zhang, B. AU - Keating, N. L. AU - Weeks, J. C. AU - Prigerson, H. G. PY - 2014 DA - 2014// TI - Associations between palliative chemotherapy and adult cancer patients’ end of life care and place of death: prospective cohort study JO - Bmj VL - 348 UR - https://doi.org/10.1136/bmj.g1219 DO - 10.1136/bmj.g1219 ID - Wright2014 ER - TY - JOUR AU - Cheon, S. AU - Agarwal, A. AU - Popovic, M. AU - Milakovic, M. AU - Lam, M. AU - Fu, W. AU - DiGiovanni, J. AU - Lam, H. AU - Lechner, B. AU - Pulenzas, N. PY - 2016 DA - 2016// TI - The accuracy of clinicians' predictions of survival in advanced cancer: a review JO - Ann Palliat Med VL - 5 ID - Cheon2016 ER - TY - JOUR AU - Su, C. AU - Zhou, F. AU - Shen, J. AU - Zhao, J. AU - O'Brien, M. PY - 2017 DA - 2017// TI - Treatment of elderly patients or patients who are performance status 2 (PS2) with advanced non-small cell lung Cancer without epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) translocations - still a daily challenge JO - Eur J Cancer VL - 83 UR - https://doi.org/10.1016/j.ejca.2017.07.002 DO - 10.1016/j.ejca.2017.07.002 ID - Su2017 ER - TY - JOUR AU - Rochigneux, P. AU - Raoul, J. L. AU - Beaussant, Y. AU - Aubry, R. AU - Goldwasser, F. AU - Tournigand, C. AU - Morin, L. PY - 2017 DA - 2017// TI - Use of chemotherapy near the end of life: what factors matter JO - Ann Oncol VL - 28 ID - Rochigneux2017 ER - TY - JOUR AU - Ferrell, B. R. AU - Temel, J. S. AU - Temin, S. AU - Alesi, E. R. AU - Balboni, T. A. AU - Basch, E. M. AU - Firn, J. I. AU - Paice, J. A. AU - Peppercorn, J. M. AU - Phillips, T. PY - 2017 DA - 2017// TI - Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2016.70.1474 DO - 10.1200/JCO.2016.70.1474 ID - Ferrell2017 ER - TY - JOUR AU - Braga, S. PY - 2011 DA - 2011// TI - Why do our patients get chemotherapy until the end of life? JO - Ann Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdr416 DO - 10.1093/annonc/mdr416 ID - Braga2011 ER - TY - JOUR AU - Emanuel, E. J. AU - Young-Xu, Y. AU - Levinsky, N. G. AU - Gazelle, G. AU - Saynina, O. AU - Ash, A. S. PY - 2003 DA - 2003// TI - Chemotherapy use among Medicare beneficiaries at the end of life JO - Ann Intern Med VL - 138 UR - https://doi.org/10.7326/0003-4819-138-8-200304150-00011 DO - 10.7326/0003-4819-138-8-200304150-00011 ID - Emanuel2003 ER - TY - JOUR AU - Hashimoto, K. AU - Yonemori, K. AU - Katsumata, N. AU - Hotchi, M. AU - Kouno, T. AU - Shimizu, C. AU - Tamura, K. AU - Ando, M. AU - Takeuchi, M. AU - Fujiwara, Y. PY - 2009 DA - 2009// TI - Factors that affect the duration of the interval between the completion of palliative chemotherapy and death JO - Oncologist VL - 14 UR - https://doi.org/10.1634/theoncologist.2008-0257 DO - 10.1634/theoncologist.2008-0257 ID - Hashimoto2009 ER - TY - JOUR AU - Caires-Lima, R. AU - Cayres, K. AU - Protásio, B. AU - Caires, I. AU - Andrade, J. AU - Rocha, L. AU - Takahashi, T. K. AU - Hoff, P. M. AU - Castro, G. AU - Mak, M. P. PY - 2018 DA - 2018// TI - Palliative chemotherapy outcomes in patients with ECOG-PS higher than 1 JO - Ecancermedicalscience VL - 12 UR - https://doi.org/10.3332/ecancer.2018.831 DO - 10.3332/ecancer.2018.831 ID - Caires-Lima2018 ER - TY - JOUR AU - Simmons, C. P. L. AU - McMillan, D. C. AU - McWilliams, K. AU - Sande, T. A. AU - Fearon, K. C. AU - Tuck, S. AU - Fallon, M. T. AU - Laird, B. J. PY - 2017 DA - 2017// TI - Prognostic Tools in Patients With Advanced Cancer: A Systematic Review JO - J Pain Symptom Manag VL - 53 UR - https://doi.org/10.1016/j.jpainsymman.2016.12.330 DO - 10.1016/j.jpainsymman.2016.12.330 ID - Simmons2017 ER - TY - STD TI - Pembrolizumab in patients with non-small cell lung Cancer and a performance status 2 (PeePS2) [https://clinicaltrials.gov/ct2/show/NCT02733159]. UR - https://clinicaltrials.gov/ct2/show/NCT02733159 ID - ref35 ER - TY - STD TI - A study of Atezolizumab compared with chemotherapy in treatment Naïve participants with locally advanced or recurrent or metastatic non-small cell lung Cancer who are deemed unsuitable for platinum-containing therapy (IPSOS) [https://clinicaltrials.gov/ct2/show/NCT03191786]. UR - https://clinicaltrials.gov/ct2/show/NCT03191786 ID - ref36 ER - TY - JOUR AU - Matsuo, N. AU - Sekine, A. AU - Kato, T. AU - Hosoda, C. AU - Ito, H. AU - Baba, T. AU - Umeda, S. AU - Iwasawa, T. AU - Okudela, K. AU - Ogura, T. PY - 2016 DA - 2016// TI - Promising Effect of Crizotinib on Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer in an Elderly Patient with a Poor Performance Status: A Case Report and Literature Review JO - Intern Med VL - 55 UR - https://doi.org/10.2169/internalmedicine.55.5076 DO - 10.2169/internalmedicine.55.5076 ID - Matsuo2016 ER - TY - JOUR AU - Valdivieso, M. AU - Corn, B. W. AU - Dancey, J. E. AU - Wickerham, D. L. AU - Horvath, L. E. AU - Perez, E. A. AU - Urton, A. AU - Cronin, W. M. AU - Field, E. AU - Lackey, E. PY - 2015 DA - 2015// TI - The Globalization of Cooperative Groups JO - Semin Oncol VL - 42 UR - https://doi.org/10.1053/j.seminoncol.2015.07.003 DO - 10.1053/j.seminoncol.2015.07.003 ID - Valdivieso2015 ER - TY - JOUR AU - Grössmann, N. AU - Paggio, J. C. AU - Wolf, S. AU - Sullivan, R. AU - Booth, C. M. AU - Rosian, K. AU - Emprechtinger, R. AU - Wild, C. PY - 2017 DA - 2017// TI - Five years of EMA-approved systemic cancer therapies for solid tumours—a comparison of two thresholds for meaningful clinical benefit JO - Eur J Cancer VL - 82 UR - https://doi.org/10.1016/j.ejca.2017.05.029 DO - 10.1016/j.ejca.2017.05.029 ID - Grössmann2017 ER -